The global human growth hormone market size was valued at USD 6.81 billion in 2024 and is projected to reach from USD 7.63 billion in 2025 to USD 18.75 billion by 2033, growing at a CAGR of 11.90% ...

In the current age, supplements with Human Growth Hormone (HGH) have become favored due to their likely anti-aging benefits and augmentation of athletic performance. HGH, a hormone that the ...

In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

In April, 1985, the FDA banned the distribution of pituitary growth hormone (hGH) because of the possibility that it was contaminated by a “slow virus”. All parents of children receiving hGH ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

The Food and Drug Administration lifted that ban in ... For more information, patients treated with cadaver-derived human ...

On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...

Purpose: Increased blood lactate concentration has been suggested as a primary stimulus for the exercise-induced growth hormone response (EIGR). Patients with McArdle disease are unable to produce ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...